Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice

Journal of Clinical Investigation

Volumn 103, Issue 5, 1999, Pages 627-635

  Hisada, Yutaka ^a   Sugaya, Takeshi ^a   Yamanouchi, Masaya ^a   Uchida, Hiromi ^a   Fujimura, Hisako ^a   Sakurai, Hiroaki ^a   Fukamizu, Akiyoshi ^b   Murakami, Kazuo ^b  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CHEMOATTRACTANT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ARTICLE; GLOMERULOSCLEROSIS; IMMUNE MEDIATED INJURY; IMMUNOPATHOGENESIS; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; MOUSE; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0033104754     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2454     Document Type: Article

References (38)

1. Matsusaka, T., Hymes, J., and Ichikawa, I. 1996. Angiotensin in progressive renal diseases: theory and practice. J. Am. Soc. Nephrol. 7:2025-2043.
2. Yoshida, Y., Kawamura, M., Ikomo, A., Fogo, A., and Ichikawa, I. 1989. Effects of antihypertensive drugs on glomerular morphology. Kidney Int. 36:626-635.
3. Lafayette, R.A., Mayer, G., Park, S.K., and Meyer, T.W. 1992. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90:766-771.
4. de Zeeuw, D., Heeg, J.E., and de Joung, P.E. 1992. The antiproteinuric effect of angiotensin converting enzyme inhibitors in human renal disease. In International yearbook of nephrology. V.E. Andreucci and L.G. Fine, editors. Springer-Verlag. London, United Kingdom. 95-113.
5. Brunner, H.R. 1992. ACE inhibitors in renal disease. Kidney Int. 42:463-479.
6. Anderson, S., Rennke, H.G., and Brenner, B.M. 1986. Therapeutic advantages of converting inhibitors in arresting progressive renal disease associated with systemic hypertension in the rats. J. Clin. Invest. 77:1993-2000.
7. Ravid, M., et al. 1993. Long term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann. Intern. Med. 118:577-581.
8. Egido, J. 1996. Vasoactive hormones and renal sclerosis. Kidney Int. 49:578-598.
9. Gansevoort, R.T., de Zeeuw, D., and de Jong, P.E. 1993. Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease. Am. J. Kidney Dis. 22:202-206.
10. Ruiz-Ortega, M., et al. 1995. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int. 48:1778-1791.
11. Wilson, C.B., and Dixon, F.J. 1981. The renal response to immunological injury. In The kidney. 2nd ed. B.M. Brenner and F.D. Rector, Jr., editors. W.B. Saunders. Philadelphia, PA. 1247-1255.
12. Timmermans, V., Peake, P.W., Charlesworth, J.A., Macdonald, G.J., and Pawlak, M.A. 1990. Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis. Kidney Int. 38:518-524.
13. Yayama, K., et al. 1995. Activation of the renin-angiotensin system in anti-glomerular basement membrane antibody-induced glomerulonephritis. Biol. Pharm. Bull. 18:411-415.
14. Zhou, J., Song, K., Harris, P.J., and Mendelssohn, F.A. 1992. In vitro autoradiography reveals predominantly ATI angiotensin II receptors in rat kidney. Renal Physiol. Biochem. 15:231-239.
15. Du, Y., Yao, A., Guo, D.F., Inagami, T., and Wang, D.H. 1995. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension. 25:872-877.
16. Sugaya, T., et al. 1995. Angiotensin II type 1a receptor deficient mice with hypotension and hyperreninemia. J. Biol. Chem. 270:18719-18722.
17. Piccini, N., Knopf, J.L., and Gross, K.W. 1982. A DNA polymorphism, consistent with gene duplication, correlates with high renin levels in the mouse submaxillary gland. Cell. 30:205-213.
18. Tanimoto, K., Tamura, K., Sugiyama, F., Murakami, K. and Fukamizu, A. 1993. Isolation of the mouse Ren-1C gene and characterization of renin gene expression in both ES-D3 cells and their parental mouse strain. J. Reprod. Dev. 39:19-24.
19. Nagai, H., Takizawa, T., Nishiyori, T., and Koda, A. 1982. Experimental glomerulonephritis in mice as a model for immunopharmacological studies. Jpn. J. Pharmacol. 32:1117-1124.
20. Hatae, T., Takimoto, E., Murakami, K., and Fukamizu, A. 1994. Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol. Cell. Biochem. 131:43-47.
21. Fukamizu, A., et al. 1993. Chimeric renin-angiotensin system demonstrate sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J. Biol. Chem. 268:11617-11621
22. Tanimoto, K., et al. 1994. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269:31334-31337.
23. Sakurai, H., et al. 1996. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochem. Biophys. Acta. 1316:132-138.
24. Floege, J., et al. 1991. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 40:477-488.
25. Shih, W., Hines, W.H., and Neilson, E.G. 1988. Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int. 33:1113-1118.
26. Tang, W.W., Qi, M., and Warren, J.S. 1996. Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int. 50:665-671.
27. 1A receptor-deficient mice. J. Am. Soc. Nephrol. 8:406A. (Abstr.)
28. Boyce, N.W., and Holdsworth, S.R. 1987. Intra-renal haemodynamic alterations induced by anti-GBM antibody. Kidney Int. 31:8-14.
29. Brasier, A.R., and Li, J. 1996. Mechanism for inducible control of angiotensinogen gene transcription. Hypertension. 27:465-475.
30. Rozzo, S.J., Vyse, T.J., Drake, C.G., and Kotzin, B.L. 1996. Effect of genetic background on the contribution of New Zealand Black loci to autoimmune lupus nephritis. Proc. Natl. Acad. Sci. USA. 93:15164-15168.
31. Kimura, M., et al. 1993. Interstrain differences in murine daunomycin-induced nephritis. Nephron. 63:193-198.
32. Stahl, R.A.K., et al. 1993. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int. 44:1036-1047.
33. Schlöndorff, D., Nelson, P.J., Luckow, B., and Banas, B. 1997. Chemokines and renal disease. Kidney Int. 51:610-621.
34. Lloyd, C.M., et al. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185:1371-1380.
35. Ruiz-Ortega, M., et al. 1998. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J. Immunol. 161:430-439.
36. Goetzel, E.J., Klickstein, L.B., Watt, K.W.K., and Wintroub, B.U. 1980. The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. Biochem. Biophys. Res. Commun. 97:1097-1102.
37. Kagami, S., Border, WA, Miller, D.E., and Noble, N.A. 1994. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:2431-2437.
38. Yayama, T., Makino, J., Takano, M., and Okamoto, H. 1995. Role of angiotensin II in the transforming growth factor-β1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis. Biol. Pharm. Bull. 18:687-690.